explore -WSS

explore

author：explore 2025-09-30 00:50:48 - browse：72

Richard Neal. -- health policy coverage from STAT — Rep. Richard Neal (D-Mass.) Drew Angerer/Getty Images

WASHINGTON — A rift between Democrats and Republicans over health care transparency was on full display in the House on Wednesday.

Republicans on the House Ways & Means Committee introduced a package this week that they say would increase health care transparency, but Democrats and outside groups are arguing that it doesn’t go far enough to force companies to disclose information about their ownership. They also think it goes too easy on the private equity firms that are buying up health care practices.

“There was an opportunity here for bipartisanship, but I think we ought to reference that in the past tense,” said ranking Democrat Richard Neal (D-Mass.).

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： What does generative AI mean for health care? We asked experts
Next article： Regeneron agrees to White House price limits on anti

focus

WSS

Private equity could exacerbate cardiology's overuse problem, experts fear

What to make of Biden’s latest efforts on cancer research

Pig kidney works a record two months in donated body

Humans aren't the only ones with an imagination. Rats have it too

DeepMind touts AlphaFold's new skills as protein folding AI models face off

FDA panel endorses Alnylam’s heart drug — after picking it apart

hotspot

explore

Wikipedia

Peter Hotez and the public health issue of online harassment

WATCH: Why do bright lights make us see spots?

After affirmative action ruling, medical educators look to 'holistic review'

Infant mortality in U.S. rose last year for first time in decades: CDC

Psychedelics group wrestles with new pharma identity

The health care issue Democrats can’t solve: hospital reform

Trump demands the U.S. pay no more for drugs than other countries … again

Brain injuries and the importance of a second opinion

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

A common UTI test for kids haunts adults as a traumatic 'nightmare'

leisure time

Nick Leschly quits Bluebird Bio spinout amid restructuring, layoffs

White House touts steps to stem shortages of cancer treatments

Bill would allow buprenorphine prescription for addiction via telehealth

Generate Biomedicines machine learning biotech raises $273M

Readout LOUD podcast: ESMO highlights & Roivant's big deal

What to make of Biden’s latest efforts on cancer research

leisure time

entertainment

focus

explore